About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 30 record(s)
Req # A-2022-09230
All correspondence between PMPRB Executive Director Doug Clark and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09231
Copies of all PMPRB Board minutes and materials (briefing materials, presentations, staff recommendations) pertaining to the October 2022 revised draft Guidelines.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09622
All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2020-18439
Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10646
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Nothing to report this month
Organization: Canada Development Investment Corporation
Req # A 2020_0001
Provide copies of any and all communication and information records produced between May 1, 2018, and March 6, 2020 regarding the potential of the federal governments selling equity in TMP, TMEP, and related government-owned assets, and any related considerations and analysis. This includes any and all letters or e-mails between employees and/or board members of CDIC (including employees and board members of the CDIC subsidiary Trans Mountain Corporation) and the Department of Finance or the office of the Minister of Finance. This also includes memos, briefing materials, background documents, research and analysis, powerpoint presentations, or any other written materials produced for internal consideration at CDIC or for review by officials at the Department of Finance or the office of the Minister of Finance.Organization: Canada Development Investment Corporation
February 2021
Req # A 2020_0008
The letter from Trans Mountain to CDEV referred to in the June 2019 minutes in screen shot [Letter from TMC to Minister of Finance and CDEV].Organization: Canada Development Investment Corporation
February 2021
Req # A-2020-00811
Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.Organization: Patented Medicine Prices Review Board Canada
February 2021